Advertisement
Screener

ACLARION, INC. (ACON) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

ACLARION, INC. Increase (Decrease) in Accounts Receivable

ACLARION, INC. (ACON) reported Increase (Decrease) in Accounts Receivable of -$1.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06

  • ACLARION, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$12.41K, a 810.82% decline year-over-year.
  • ACLARION, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $10.90K, a 1184.22% increase year-over-year.
  • ACLARION, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.34K.
  • ACLARION, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $11.10K.
  • ACLARION, INC. increase (decrease) in accounts receivable for fiscal 2025 was $11.35K.
  • ACLARION, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$7.27K, a 587.66% decline from fiscal 2023.
  • ACLARION, INC. increase (decrease) in accounts receivable for fiscal 2023 was $1.49K, a 87.87% decline from fiscal 2022.
  • ACLARION, INC. increase (decrease) in accounts receivable for fiscal 2022 was $12.29K.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30-$12.41K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.51K
10-Q · filed 2026-08-06
-$3.85K
derived: sum of 3 quarters · filed 2026-08-06
$7.25K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$10.90K
10-Q · filed 2026-05-13
$8.56K
derived: sum of 2 quarters · filed 2026-05-13
$19.66K
derived: sum of 3 quarters · filed 2026-05-13
$21.41K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$2.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$8.76K
derived: sum of 2 quarters · filed 2026-03-18
$10.51K
derived: sum of 3 quarters · filed 2026-08-06
$11.35K
10-K · filed 2026-03-18
2025-09-30$11.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$12.84K
derived: sum of 2 quarters · filed 2026-08-06
$13.69K
10-Q · filed 2025-11-12
$4.07K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.60K
10-Q · filed 2026-08-06
-$7.03K
derived: sum of 3 quarters · filed 2026-08-06
-$9.79K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$849.00
10-Q · filed 2026-05-13
-$8.77K
derived: sum of 2 quarters · filed 2026-05-13
-$11.54K
derived: sum of 3 quarters · filed 2026-05-13
-$9.04K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$9.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$12.39K
derived: sum of 2 quarters · filed 2026-03-18
-$9.89K
derived: sum of 3 quarters · filed 2026-03-18
-$7.27K
10-K · filed 2026-03-18
2024-09-30-$2.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$265.00
derived: sum of 2 quarters · filed 2025-11-12
$2.35K
10-Q · filed 2025-11-12
-$5.57K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$2.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$5.12K
10-Q · filed 2025-08-14
-$2.80K
derived: sum of 3 quarters · filed 2025-08-14
$8.02K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$2.62K
10-Q · filed 2025-05-15
-$5.30K
derived: sum of 2 quarters · filed 2025-05-15
$5.52K
derived: sum of 3 quarters · filed 2025-05-15
$5.52K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$7.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09
$2.90K
derived: sum of 2 quarters · filed 2025-04-09
$2.91K
derived: sum of 3 quarters · filed 2025-04-09
$1.49K
10-K · filed 2025-04-09
2023-09-30$10.82K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$10.82K
derived: sum of 2 quarters · filed 2024-11-14
$9.41K
10-Q · filed 2024-11-14
$2.48K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$2.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$1.41K
10-Q · filed 2024-08-14
-$8.34K
derived: sum of 3 quarters · filed 2024-08-14
$12.12K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$1.42K
10-Q · filed 2024-05-15
-$8.35K
derived: sum of 2 quarters · filed 2024-05-15
$12.12K
derived: sum of 3 quarters · filed 2024-05-15
$4.63K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$6.93K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$13.53K
derived: sum of 2 quarters · filed 2024-03-28
$6.05K
derived: sum of 3 quarters · filed 2024-03-28
$12.29K
10-K · filed 2024-03-28
2022-09-30$20.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$12.98K
derived: sum of 2 quarters · filed 2023-11-14
$19.22K
10-Q · filed 2023-11-14
$14.82K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$7.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25
-$1.24K
10-Q · filed 2023-08-25
$1.24K
10-Q · filed 2022-08-15
-$5.64K
derived: sum of 3 quarters · filed 2023-08-25
-$29.38K
derived: sum of 4 quarters · filed 2023-08-25
2022-03-31$6.24K
10-Q · filed 2023-07-03
$1.84K
derived: sum of 2 quarters · filed 2023-07-03
-$21.90K
derived: sum of 3 quarters · filed 2023-07-03
-$18.60K
derived: sum of 4 quarters · filed 2023-07-03
2021-12-31-$4.40K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12
-$28.14K
derived: sum of 2 quarters · filed 2023-06-12
-$24.84K
derived: sum of 3 quarters · filed 2023-06-12
-$16.22K
10-K/A · filed 2023-06-12
2021-09-30-$23.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$20.44K
derived: sum of 2 quarters · filed 2022-11-14
-$11.82K
10-Q · filed 2022-11-14
2021-06-30$3.30K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$11.92K
10-Q · filed 2022-08-15
2021-03-31$8.62K
10-Q · filed 2022-06-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45